ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/08/20 | 3,365 | 3,470 | 3,205 | 3,345 | +160 | +5% | 332,600 |
| 2018/08/17 | 3,000 | 3,190 | 2,976 | 3,185 | +260 | +8.9% | 216,900 |
| 2018/08/16 | 2,863 | 2,989 | 2,803 | 2,925 | -38 | -1.3% | 256,500 |
| 2018/08/15 | 3,200 | 3,225 | 2,931 | 2,963 | -307 | -9.4% | 399,000 |
| 2018/08/14 | 3,115 | 3,325 | 3,115 | 3,270 | +175 | +5.7% | 184,800 |
| 2018/08/13 | 3,210 | 3,215 | 3,060 | 3,095 | -70 | -2.2% | 147,600 |
| 2018/08/10 | 3,205 | 3,250 | 3,160 | 3,165 | -15 | -0.5% | 67,100 |
| 2018/08/09 | 3,220 | 3,280 | 3,135 | 3,180 | -75 | -2.3% | 68,300 |
| 2018/08/08 | 3,115 | 3,310 | 3,110 | 3,255 | +125 | +4% | 107,700 |
| 2018/08/07 | 3,030 | 3,180 | 3,030 | 3,130 | +30 | +1% | 129,200 |
| 2018/08/06 | 3,230 | 3,250 | 3,080 | 3,100 | -200 | -6.1% | 222,900 |
| 2018/08/03 | 3,435 | 3,465 | 3,295 | 3,300 | -135 | -3.9% | 105,300 |
| 2018/08/02 | 3,280 | 3,450 | 3,280 | 3,435 | +105 | +3.2% | 87,600 |
| 2018/08/01 | 3,405 | 3,445 | 3,325 | 3,330 | -75 | -2.2% | 87,600 |
| 2018/07/31 | 3,340 | 3,430 | 3,260 | 3,405 | +15 | +0.4% | 153,600 |
| 2018/07/30 | 3,555 | 3,555 | 3,385 | 3,390 | -165 | -4.6% | 179,800 |
| 2018/07/27 | 3,550 | 3,585 | 3,510 | 3,555 | +30 | +0.9% | 66,300 |
| 2018/07/26 | 3,615 | 3,630 | 3,520 | 3,525 | -20 | -0.6% | 96,000 |
| 2018/07/25 | 3,585 | 3,590 | 3,540 | 3,545 | -10 | -0.3% | 57,900 |
| 2018/07/24 | 3,620 | 3,635 | 3,530 | 3,555 | -15 | -0.4% | 104,900 |
| 2018/07/23 | 3,655 | 3,715 | 3,565 | 3,570 | -175 | -4.7% | 166,900 |
| 2018/07/20 | 3,810 | 3,870 | 3,720 | 3,745 | -90 | -2.3% | 96,400 |
| 2018/07/19 | 3,785 | 3,895 | 3,740 | 3,835 | +50 | +1.3% | 120,800 |
| 2018/07/18 | 3,650 | 3,820 | 3,650 | 3,785 | +135 | +3.7% | 113,700 |
| 2018/07/17 | 3,660 | 3,715 | 3,640 | 3,650 | -45 | -1.2% | 75,400 |
| 2018/07/13 | 3,700 | 3,730 | 3,655 | 3,695 | +20 | +0.5% | 75,500 |
| 2018/07/12 | 3,640 | 3,705 | 3,610 | 3,675 | +65 | +1.8% | 66,400 |
| 2018/07/11 | 3,650 | 3,680 | 3,530 | 3,610 | -95 | -2.6% | 139,000 |
| 2018/07/10 | 3,730 | 3,765 | 3,655 | 3,705 | +20 | +0.5% | 119,000 |
| 2018/07/09 | 3,780 | 3,875 | 3,625 | 3,685 | -95 | -2.5% | 238,000 |
| 2018/07/06 | 3,630 | 3,780 | 3,575 | 3,780 | +265 | +7.5% | 301,200 |
| 2018/07/05 | 3,845 | 3,935 | 3,450 | 3,515 | -385 | -9.9% | 479,900 |
| 2018/07/04 | 4,075 | 4,075 | 3,780 | 3,900 | -185 | -4.5% | 351,600 |
| 2018/07/03 | 4,590 | 4,630 | 4,065 | 4,085 | -475 | -10.4% | 297,000 |
| 2018/07/02 | 4,885 | 4,885 | 4,555 | 4,560 | -325 | -6.7% | 121,900 |
| 2018/06/29 | 4,745 | 4,885 | 4,705 | 4,885 | +125 | +2.6% | 67,500 |
| 2018/06/28 | 4,800 | 4,805 | 4,700 | 4,760 | -85 | -1.8% | 86,900 |
| 2018/06/27 | 4,870 | 4,930 | 4,655 | 4,845 | +4,356 | +890.8% | 107,400 |
| 2018/06/26 | 466 | 490 | 464 | 489 | +13 | +2.7% | 836,000 |
| 2018/06/25 | 498 | 501 | 476 | 476 | -25 | -5% | 1,205,000 |
| 2018/06/22 | 507 | 510 | 499 | 501 | -13 | -2.5% | 1,310,000 |
| 2018/06/21 | 512 | 518 | 509 | 514 | +2 | +0.4% | 1,301,000 |
| 2018/06/20 | 504 | 513 | 496 | 512 | +7 | +1.4% | 1,653,000 |
| 2018/06/19 | 502 | 508 | 496 | 505 | +2 | +0.4% | 1,654,000 |
| 2018/06/18 | 508 | 515 | 500 | 503 | +2 | +0.4% | 1,586,000 |
| 2018/06/15 | 510 | 512 | 499 | 501 | -2 | -0.4% | 1,004,000 |
| 2018/06/14 | 517 | 521 | 502 | 503 | -6 | -1.2% | 1,498,000 |
| 2018/06/13 | 504 | 516 | 500 | 509 | +9 | +1.8% | 1,591,000 |
| 2018/06/12 | 479 | 511 | 479 | 500 | +24 | +5% | 3,070,000 |
| 2018/06/11 | 471 | 480 | 470 | 476 | +3 | +0.6% | 1,132,000 |
1701～
1750
件表示中 / 3759件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 296,800円 | +21.7% | +999.9% | 0.00% | 12.44倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 388,100円 | -6.4% | -71.8% | 4.90% | 43.35倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 294,600円 | +7.9% | -3.3% | 2.72% | 8.19倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 持田薬 | 322,500円 | +5.1% | -7.0% | 2.48% | 21.17倍 | 0.87倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 202,400円 | +3.1% | -6.5% | 2.37% | 9.39倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
